NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160046616A1
SERIAL NO

14774956

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Small molecule inhibitors of Nrf2 and methods of their use are provided for treating or preventing a disease, disorder or condition associated with an Nrf2-regulated pathway. The compound can be administered as a single agent or can be administered to enhance the efficacy of a chemotherapeutic drug and/or radiation therapy.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITY3400 N CHARLES STREET BALTIMORE MD 21218

International Classification(s)

loading....
  • 2014 Application Filing Year
  • C07D Class
  • 5203 Applications Filed
  • 4627 Patents Issued To-Date
  • 88.93 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances201420152016201720182019202020212022202320240255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BISWAL, SHYAM S BALTIMORE, US 1 6
BOXER, MATTHEW B ROCKVILLE, US 12 52
OH, KYU BALTIMORE, US 1 6
RASTINEJAD, FRAYDOON ORLANDO, US 2 29
ROHDE, JASON M ROCKVILLE, US 2 7
SHEN, MIN ROCKVILLE, US 78 291
SINGH, ANJU BALTIMORE, US 5 25
VENKANNAGARI, SREEDHAR BALTIMORE, US 1 6
ZHANG, YA-QIN ROCKVILLE, US 73 3429

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 6 Citation Count
  • C07D Class
  • 36.67 % this patent is cited more than
  • 9 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges137619812528031834145701 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0100200300400500600700800900100011001200130014001500160017001800190020002100

Forward Cite Landscape

Load Citation